Clinical comparison of extended-release divalproex versus delayed-release divalproex: pooled data analyses from nine trials

Epilepsy & Behavior : E&B
Michael C SmithMichelle A Collins

Abstract

Divalproex sodium is an effective anticonvulsant, antimanic, and migraine prophylaxis agent. Recently, a new extended-release (ER) formulation of divalproex sodium has become available, which allows for once-daily dosing and provides prolonged therapeutic serum levels. Using data pooled from nine open-label trials involving 321 epilepsy and psychiatry patients, we compared the efficacy and tolerability of divalproex ER with preceding treatment with the older delayed-release (DR) formulation, based on patient reports and analysis by McNemar's test for within-subject paired data. Divalproex ER was associated with superior tolerability with less frequent tremor, weight gain, and gastrointestinal complaints (all P<0.001), but not less hair loss. Divalproex ER also yielded improved seizure control and greater improvement of psychiatric symptoms, and was greatly preferred by patients over divalproex DR. Although the results of the current analyses must be considered highly tentative due to the open-label nature of the trials included, the findings do suggest broad clinical superiority of the new ER preparation.

References

Mar 1, 1995·Archives of Neurology·N T MathewR L Deaton
Mar 23, 1994·JAMA : the Journal of the American Medical Association·C L BowdenJ G Small
May 20, 1999·The New England Journal of Medicine·O Devinsky
Mar 16, 2001·Expert Opinion on Pharmacotherapy·J W Wheless, V Venkataraman
Jun 12, 2002·Neurology·Frederick G FreitagUNKNOWN Depakote ER Migraine Study Group

❮ Previous
Next ❯

Citations

May 16, 2013·CNS Drugs·Athanasios Gaitatzis, Josemir W Sander
Mar 20, 2010·Expert Opinion on Drug Metabolism & Toxicology·Brigitte V Lovell, Michael J Marmura
Jul 20, 2007·Current Medical Research and Opinion·Glen T SchumockJoyce A Cramer
Jun 19, 2015·Current Psychiatry Reports·Andrea MurruEduard Vieta
Nov 26, 2010·Seizure : the Journal of the British Epilepsy Association·S DedeurwaerdereT J O'Brien
Sep 11, 2014·Epilepsy Research·Patsy RameyBassel Abou-Khalil
May 11, 2016·The International Journal of Neuroscience·Sherifa A Hamed, Mostafa M Abdellah
Mar 5, 2009·Journal of Child Neurology·Cynthia SharpeDoris A Trauner
Jul 11, 2007·Journal of Child Neurology·Alberto VerrottiFrancesco Chiarelli
Mar 29, 2019·Continuum : Lifelong Learning in Neurology·Bassel W Abou-Khalil
Nov 30, 2018·Expert Opinion on Pharmacotherapy·Monika BanachStanisław J Czuczwar

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bipolar Disorder

Bipolar disorder is characterized by manic and/or depressive episodes and associated with uncommon shifts in mood, activity levels, and energy. Discover the latest research this illness here.